Akute Myopisierung nach einer Einzeldosis Acetazolamid: Fallbericht und Literaturrecherche [Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature]
Détails
Télécharger: 38653306_BIB_3A636D04C5DC.pdf (214.58 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_3A636D04C5DC
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Akute Myopisierung nach einer Einzeldosis Acetazolamid: Fallbericht und Literaturrecherche [Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature]
Périodique
Klinische Monatsblatter fur Augenheilkunde
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Statut éditorial
Publié
Date de publication
04/2024
Peer-reviewed
Oui
Volume
241
Numéro
4
Pages
554-558
Langue
anglais
Notes
Publication types: Journal Article ; Case Reports ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
We report the case of a 32-year-old male who presented with an acute myopic shift as a result of uveal effusion following a single administration of 250 mg acetazolamide. The drug was discontinued and following cycloplegia and topical steroid therapy, we observed progressive deepening of the anterior chamber, reopening of the iridocorneal angle, and complete resolution of the myopic shift after 5 days. A literature review since 1956 identified 23 cases, including ours, which developed a myopic shift after a median time of 24 h (3 - 24) following a median dose of 500 mg (125 - 1000) acetazolamide, with about a third complicated by angle closure ocular hypertension. This presumed idiosyncratic reaction can occur without prior drug exposure and independent of the phakic status. Treatment options include systematic drug withdrawal associated with cycloplegia, anti-glaucomatous agents, and/or corticosteroids. Full recovery is achieved within about 5 days (2 - 14). Given the widespread use of acetazolamide, awareness of this idiosyncratic reaction is crucial to avoid complications of acute angle-closure glaucoma.
Mots-clé
Humans, Acetazolamide/therapeutic use, Acetazolamide/adverse effects, Acetazolamide/administration & dosage, Male, Adult, Myopia/chemically induced, Myopia/drug therapy, Carbonic Anhydrase Inhibitors/adverse effects, Carbonic Anhydrase Inhibitors/administration & dosage, Carbonic Anhydrase Inhibitors/therapeutic use, Acute Disease, Treatment Outcome
Pubmed
Web of science
Open Access
Oui
Création de la notice
29/04/2024 9:01
Dernière modification de la notice
09/08/2024 14:57